世界のじん肺症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pneumoconiosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4722
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、じん肺症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（粘液溶解剤、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・じん肺症治療の市場動向
・企業の競争状況、市場シェア
・じん肺症治療の種類別市場規模と予測2016-2027（粘液溶解剤、抗生物質、その他）
・じん肺症治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・じん肺症治療の北米市場規模2016-2027（アメリカ、カナダ）
・じん肺症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・じん肺症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・じん肺症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・じん肺症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Sanofi、Abbott、Roche、Bayer、Novartis、AstraZeneca、Merck、Eli Lilly、Novo Nordisk、Sun Pharmaceutical）
・結論

Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture.

Market Analysis and Insights: Global Pneumoconiosis Treatment Market
The global Pneumoconiosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumoconiosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumoconiosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumoconiosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumoconiosis Treatment market.

Global Pneumoconiosis Treatment Scope and Market Size
Pneumoconiosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumoconiosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mucolytic Agent
Antibiotic
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Sanofi
Abbott
Roche
Bayer
Novartis
AstraZeneca
Merck
Eli Lilly
Novo Nordisk
Sun Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumoconiosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mucolytic Agent
1.2.3 Antibiotic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pneumoconiosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pneumoconiosis Treatment Market Perspective (2016-2027)
2.2 Pneumoconiosis Treatment Growth Trends by Regions
2.2.1 Pneumoconiosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumoconiosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pneumoconiosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pneumoconiosis Treatment Industry Dynamic
2.3.1 Pneumoconiosis Treatment Market Trends
2.3.2 Pneumoconiosis Treatment Market Drivers
2.3.3 Pneumoconiosis Treatment Market Challenges
2.3.4 Pneumoconiosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pneumoconiosis Treatment Players by Revenue
3.1.1 Global Top Pneumoconiosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Pneumoconiosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pneumoconiosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumoconiosis Treatment Revenue
3.4 Global Pneumoconiosis Treatment Market Concentration Ratio
3.4.1 Global Pneumoconiosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumoconiosis Treatment Revenue in 2020
3.5 Pneumoconiosis Treatment Key Players Head office and Area Served
3.6 Key Players Pneumoconiosis Treatment Product Solution and Service
3.7 Date of Enter into Pneumoconiosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pneumoconiosis Treatment Breakdown Data by Type
4.1 Global Pneumoconiosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pneumoconiosis Treatment Forecasted Market Size by Type (2022-2027)

5 Pneumoconiosis Treatment Breakdown Data by Application
5.1 Global Pneumoconiosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pneumoconiosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pneumoconiosis Treatment Market Size (2016-2027)
6.2 North America Pneumoconiosis Treatment Market Size by Type
6.2.1 North America Pneumoconiosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Pneumoconiosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Pneumoconiosis Treatment Market Size by Type (2016-2027)
6.3 North America Pneumoconiosis Treatment Market Size by Application
6.3.1 North America Pneumoconiosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Pneumoconiosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Pneumoconiosis Treatment Market Size by Application (2016-2027)
6.4 North America Pneumoconiosis Treatment Market Size by Country
6.4.1 North America Pneumoconiosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Pneumoconiosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pneumoconiosis Treatment Market Size (2016-2027)
7.2 Europe Pneumoconiosis Treatment Market Size by Type
7.2.1 Europe Pneumoconiosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pneumoconiosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pneumoconiosis Treatment Market Size by Type (2016-2027)
7.3 Europe Pneumoconiosis Treatment Market Size by Application
7.3.1 Europe Pneumoconiosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pneumoconiosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pneumoconiosis Treatment Market Size by Application (2016-2027)
7.4 Europe Pneumoconiosis Treatment Market Size by Country
7.4.1 Europe Pneumoconiosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pneumoconiosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pneumoconiosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pneumoconiosis Treatment Market Size by Type
8.2.1 Asia-Pacific Pneumoconiosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pneumoconiosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pneumoconiosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pneumoconiosis Treatment Market Size by Application
8.3.1 Asia-Pacific Pneumoconiosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumoconiosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumoconiosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumoconiosis Treatment Market Size by Region
8.4.1 Asia-Pacific Pneumoconiosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumoconiosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pneumoconiosis Treatment Market Size (2016-2027)
9.2 Latin America Pneumoconiosis Treatment Market Size by Type
9.2.1 Latin America Pneumoconiosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pneumoconiosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pneumoconiosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Pneumoconiosis Treatment Market Size by Application
9.3.1 Latin America Pneumoconiosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pneumoconiosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pneumoconiosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Pneumoconiosis Treatment Market Size by Country
9.4.1 Latin America Pneumoconiosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pneumoconiosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pneumoconiosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pneumoconiosis Treatment Market Size by Type
10.2.1 Middle East & Africa Pneumoconiosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pneumoconiosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pneumoconiosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pneumoconiosis Treatment Market Size by Application
10.3.1 Middle East & Africa Pneumoconiosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumoconiosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumoconiosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumoconiosis Treatment Market Size by Country
10.4.1 Middle East & Africa Pneumoconiosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumoconiosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumoconiosis Treatment Introduction
11.1.4 Pfizer Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pneumoconiosis Treatment Introduction
11.2.4 Sanofi Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Pneumoconiosis Treatment Introduction
11.3.4 Abbott Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Pneumoconiosis Treatment Introduction
11.4.4 Roche Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Pneumoconiosis Treatment Introduction
11.5.4 Bayer Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pneumoconiosis Treatment Introduction
11.6.4 Novartis Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pneumoconiosis Treatment Introduction
11.7.4 AstraZeneca Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Pneumoconiosis Treatment Introduction
11.8.4 Merck Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Pneumoconiosis Treatment Introduction
11.9.4 Eli Lilly Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Pneumoconiosis Treatment Introduction
11.10.4 Novo Nordisk Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.10.5 Novo Nordisk Recent Development
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Company Details
11.11.2 Sun Pharmaceutical Business Overview
11.11.3 Sun Pharmaceutical Pneumoconiosis Treatment Introduction
11.11.4 Sun Pharmaceutical Revenue in Pneumoconiosis Treatment Business (2016-2021)
11.11.5 Sun Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pneumoconiosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mucolytic Agent
Table 3. Key Players of Antibiotic
Table 4. Key Players of Others
Table 5. Global Pneumoconiosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pneumoconiosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pneumoconiosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pneumoconiosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Pneumoconiosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pneumoconiosis Treatment Market Share by Regions (2022-2027)
Table 11. Pneumoconiosis Treatment Market Trends
Table 12. Pneumoconiosis Treatment Market Drivers
Table 13. Pneumoconiosis Treatment Market Challenges
Table 14. Pneumoconiosis Treatment Market Restraints
Table 15. Global Pneumoconiosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pneumoconiosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Pneumoconiosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumoconiosis Treatment as of 2020)
Table 18. Ranking of Global Top Pneumoconiosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pneumoconiosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pneumoconiosis Treatment Product Solution and Service
Table 22. Date of Enter into Pneumoconiosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pneumoconiosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Pneumoconiosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pneumoconiosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pneumoconiosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pneumoconiosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Pneumoconiosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pneumoconiosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pneumoconiosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pneumoconiosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pneumoconiosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pneumoconiosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pneumoconiosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pneumoconiosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pneumoconiosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pneumoconiosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pneumoconiosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pneumoconiosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pneumoconiosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pneumoconiosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pneumoconiosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pneumoconiosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pneumoconiosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pneumoconiosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pneumoconiosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pneumoconiosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pneumoconiosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pneumoconiosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pneumoconiosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pneumoconiosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pneumoconiosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pneumoconiosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pneumoconiosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pneumoconiosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Pneumoconiosis Treatment Product
Table 65. Pfizer Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Pneumoconiosis Treatment Product
Table 70. Sanofi Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott Pneumoconiosis Treatment Product
Table 75. Abbott Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Pneumoconiosis Treatment Product
Table 80. Roche Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Pneumoconiosis Treatment Product
Table 85. Bayer Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Pneumoconiosis Treatment Product
Table 90. Novartis Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Pneumoconiosis Treatment Product
Table 95. AstraZeneca Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Eli Lilly Company Details
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Pneumoconiosis Treatment Product
Table 104. Eli Lilly Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Novo Nordisk Company Details
Table 107. Novo Nordisk Business Overview
Table 108. Novo Nordisk Pneumoconiosis Treatment Product
Table 109. Novo Nordisk Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 110. Novo Nordisk Recent Development
Table 111. Sun Pharmaceutical Company Details
Table 112. Sun Pharmaceutical Business Overview
Table 113. Sun Pharmaceutical Pneumoconiosis Treatment Product
Table 114. Sun Pharmaceutical Revenue in Pneumoconiosis Treatment Business (2016-2021) & (US$ Million)
Table 115. Sun Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumoconiosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mucolytic Agent Features
Figure 3. Antibiotic Features
Figure 4. Others Features
Figure 5. Global Pneumoconiosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pneumoconiosis Treatment Report Years Considered
Figure 10. Global Pneumoconiosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pneumoconiosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pneumoconiosis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Pneumoconiosis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Pneumoconiosis Treatment Market Share by Players in 2020
Figure 15. Global Top Pneumoconiosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumoconiosis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pneumoconiosis Treatment Revenue in 2020
Figure 17. Global Pneumoconiosis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Pneumoconiosis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pneumoconiosis Treatment Market Share by Type (2016-2027)
Figure 21. North America Pneumoconiosis Treatment Market Share by Application (2016-2027)
Figure 22. North America Pneumoconiosis Treatment Market Share by Country (2016-2027)
Figure 23. United States Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pneumoconiosis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Pneumoconiosis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Pneumoconiosis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pneumoconiosis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pneumoconiosis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pneumoconiosis Treatment Market Share by Region (2016-2027)
Figure 39. China Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pneumoconiosis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Pneumoconiosis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Pneumoconiosis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pneumoconiosis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pneumoconiosis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pneumoconiosis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pneumoconiosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 68. Sun Pharmaceutical Revenue Growth Rate in Pneumoconiosis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の色汗症治療市場規模・現状・予測（2021年-2027年） Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年） Sinusitis is an inflammation or swelling of the tissue lining the sinuses. Market Analysis and Insights: Global Sinusitis Treatment Drugs Market The global Sinusitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
世界の多汗症治療市場規模・現状・予測（2021年-2027年） Hyperhidrosis is a condition characterized by abnormally increased sweating, in excess of that required for regulation of body temperature. Although primarily a physical burden, hyperhidrosis can deteriorate quality of life from a psychological, emotional, and social perspective. It has been called …
世界の黄熱病治療市場規模・現状・予測（2021年-2027年） Yellow fever is an acute infectious disease caused by yellow fever virus, mainly transmitted by the bite of aedes mosquitoes. Clinical high fever, headache, jaundice, proteinuria, relatively slow pulse and bleeding as the main manifestations. Market Analysis and Insights: Global Yellow Fever Treatme…